Shutai God: Innovations in biomedicine face many risks, such as clinical trial progress may not meet expectations.

Shutai Shen Stock Trading Abnormal Fluctuation Announcement, the company's multiple research projects belong to innovative bioproducts. Innovative biopharmaceuticals have the characteristics of high technology, high risk, and high added value. The development, clinical trials, approval process, and production cycle of innovative biopharmaceuticals are long, with many links, easily affected by factors such as technology, approval, and policies. They face many risks such as the progress of clinical trials may not meet expectations, clinical trial results may not meet expectations, and drug application for market approval may not meet expectations. Please investors, make decisions carefully and pay attention to investment risks.